BACKGROUND: Adipose tissue (AT) metabolism is altered in obese subjects, and the reestablishment of energy homeostasis requires the identification and regulation of genes with altered patterns. The aim of this study was to compare mRNA expression of PPARbeta/delta and PPARgamma1-3 in morbidly obese and nonobese patients. The expression pattern of these receptors in various abdominal adipose tissues, subcutaneous (SAT), retroperitoneal (RAT) and visceral (VAT), was also evaluated. METHODS: The AT depots were obtained by surgery. Total RNAs were extracted using TRIzol. PPARs reverse transcripts were determined by quantitative polymerase chain reaction (qRT-PCR). RESULTS: The amounts of PPARP/8 mRNA in different depots of morbidly obese AT showed a significant decrease in VAT (P < 0.05). In the non-obese group, the level of PPARbeta/delta was higher in SAT (P < 0.05), but PPARgamma1-3 was not differentially expressed in obese and non-obese depots. When comparing obese and non-obese, the results revealed a decrease in PPARPbeta/delta expression in SAT (P = 0.058) and VAT (P = 0.094) of the morbidly obese. PPARgamma1-3 mRNA expression was increased significantly in SAT (P = 0.022) and decreased in RAT (P = 0.034) in morbidly obese subjects. PPARbeta/delta expression in SAT and VAT correlated negatively with hip size and insulin serum respectively. PPARgamma1-3 expression in RAT correlated negatively with waist and hip circumference and in VAT correlated positively with waist size. CONCLUSIONS: The present study demonstrates that PPARbeta/delta and PPARgamma1-3 mRNAs are quantitatively different in AT of morbidly obese individuals compared to non-obese, and that PPARbeta/delta mRNA levels are characteristic for each AT depot.
BACKGROUND: Adipose tissue (AT) metabolism is altered in obese subjects, and the reestablishment of energy homeostasis requires the identification and regulation of genes with altered patterns. The aim of this study was to compare mRNA expression of PPARbeta/delta and PPARgamma1-3 in morbidly obese and nonobese patients. The expression pattern of these receptors in various abdominal adipose tissues, subcutaneous (SAT), retroperitoneal (RAT) and visceral (VAT), was also evaluated. METHODS: The AT depots were obtained by surgery. Total RNAs were extracted using TRIzol. PPARs reverse transcripts were determined by quantitative polymerase chain reaction (qRT-PCR). RESULTS: The amounts of PPARP/8 mRNA in different depots of morbidly obese AT showed a significant decrease in VAT (P < 0.05). In the non-obese group, the level of PPARbeta/delta was higher in SAT (P < 0.05), but PPARgamma1-3 was not differentially expressed in obese and non-obese depots. When comparing obese and non-obese, the results revealed a decrease in PPARPbeta/delta expression in SAT (P = 0.058) and VAT (P = 0.094) of the morbidly obese. PPARgamma1-3 mRNA expression was increased significantly in SAT (P = 0.022) and decreased in RAT (P = 0.034) in morbidly obese subjects. PPARbeta/delta expression in SAT and VAT correlated negatively with hip size and insulin serum respectively. PPARgamma1-3 expression in RAT correlated negatively with waist and hip circumference and in VAT correlated positively with waist size. CONCLUSIONS: The present study demonstrates that PPARbeta/delta and PPARgamma1-3 mRNAs are quantitatively different in AT of morbidly obese individuals compared to non-obese, and that PPARbeta/delta mRNA levels are characteristic for each AT depot.
Authors: Y H Lee; S Nair; E Rousseau; D B Allison; G P Page; P A Tataranni; C Bogardus; P A Permana Journal: Diabetologia Date: 2005-07-30 Impact factor: 10.122
Authors: Mohammad R Mehrabi; Petra Haslmayer; Susanne Humpeler; Gerhard Strauss-Blasche; Wolfgang Marktl; Forouzan Tamaddon; Nermin Serbecic; Georg Wieselthaler; Theresia Thalhammer; Helmut D Glogar; Cem Ekmekcioglu Journal: Eur J Heart Fail Date: 2003-12 Impact factor: 15.534
Authors: Lisa A Joss-Moore; Yan Wang; Michael S Campbell; Barry Moore; Xing Yu; Christopher W Callaway; Robert A McKnight; Mina Desai; Laurie J Moyer-Mileur; Robert H Lane Journal: Early Hum Dev Date: 2010-03-12 Impact factor: 2.079
Authors: Sara Rodríguez-Acebes; Nuria Palacios; José I Botella-Carretero; Nuria Olea; Lorena Crespo; Roberto Peromingo; Diego Gómez-Coronado; Miguel A Lasunción; Clotilde Vázquez; Javier Martínez-Botas Journal: BMC Med Genomics Date: 2010-12-23 Impact factor: 3.063
Authors: Paulina Escandon; Brenda Vasini; Amy E Whelchel; Sarah E Nicholas; H Greg Matlock; Jian-Xing Ma; Dimitrios Karamichos Journal: Exp Eye Res Date: 2021-05-16 Impact factor: 3.770
Authors: Joanne T M Tan; Victoria A Nankivell; Carmel Bilu; Tomer Shemesh; Stephen J Nicholls; Paul Zimmet; Noga Kronfeld-Schor; Alex Brown; Christina A Bursill Journal: Int J Mol Sci Date: 2019-12-13 Impact factor: 5.923
Authors: Xavier Palomer; Emma Barroso; Javier Pizarro-Delgado; Lucía Peña; Gaia Botteri; Mohammad Zarei; David Aguilar; Marta Montori-Grau; Manuel Vázquez-Carrera Journal: Int J Mol Sci Date: 2018-03-20 Impact factor: 5.923